Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2016-09-18 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
董事会关于筹划重组停牌期满申请继续停牌公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Chengdu Tianxing Instrument Co., Ltd. regarding the continuation of a trading suspension (停牌) due to the planning of a major asset restructuring (重大资产重组). It details the background, progress, and reasons for the extended suspension, including references to multiple prior announcements and meetings related to the restructuring. The document does not contain actual financial statements or detailed financial data but serves as a regulatory disclosure about the status and procedural steps of the restructuring and suspension. It is essentially an update on capital restructuring activities and the company's application to the Shenzhen Stock Exchange for continued suspension to complete the restructuring process. Given the content and purpose, this fits best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it is not merely a brief report publication announcement; it provides substantive update information on the capital restructuring process.
2016-09-18 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "重大资产重组进展公告" which translates to "Major Asset Restructuring Progress Announcement." It details a series of announcements related to the company's stock suspension due to planning a major asset restructuring, with multiple progress updates and references to regulatory compliance. The document is relatively short (981 characters) and focuses on the progress and status of a major asset restructuring, not the full details or financial statements of the restructuring itself. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings. It is not a full report, nor an announcement of a report publication, but a progress update on a capital-related event.
2016-09-12 Chinese
关于变更注册地址事项完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of a change in the company's registered address and the related business registration update. It includes details about the new address, legal representative, registered capital, and business scope. There is no financial data, no mention of financial results, no shareholder voting results, no executive changes, no legal proceedings, and no report attachments. The document is a regulatory announcement about a corporate administrative change. It is short (1062 characters) and does not contain or reference a financial report or detailed presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-09-08 Chinese
关于召开2016年第一次临时股东大会的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2016 first extraordinary general meeting (临时股东大会) of Chengdu Tianxing Instrument Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items, registration methods, and proxy authorization forms. The document does not contain any financial statements or results but serves as a notice to shareholders about the meeting and how to participate and vote. It is not a report of voting results, nor is it a proxy solicitation statement or a management report. Given the content and length (3461 characters), it fits the category of a formal meeting notice or announcement. According to the filing definitions, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into more specific categories like AGM Information (which is for presentations/materials shared during the AGM) or Declaration of Voting Results (which would report vote outcomes).
2016-09-07 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled '重大资产重组进展公告' which translates to 'Major Asset Restructuring Progress Announcement'. It details ongoing progress updates about a significant asset restructuring, including multiple dated announcements and the company's stock suspension due to this matter. The text does not contain financial statements or detailed financial data but rather updates on the status of a major restructuring event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is short (982 characters) but it is not merely announcing the publication of a report; it is itself an update on the restructuring progress. Therefore, the appropriate classification is CAP with high confidence.
2016-09-05 Chinese
独立董事独立意见
Audit Report / Information Classification · 95% confidence The document is a statement from independent directors providing their independent opinion on related party transactions and external guarantees for the half-year period of 2016. It references regulatory guidance from the China Securities Regulatory Commission (证监发[2003]56号文) and confirms the absence of related party fund occupation and external guarantees during the reporting period. The document is short (351 characters) and is a specific independent opinion rather than a full financial report or audit report. It does not contain comprehensive financial data or audit results but is a specialized statement related to governance and compliance. This fits best under Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles or regulatory compliance statements, excluding full annual reports. H1 2016
2016-08-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.